Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of Oncology

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdn351PMID 18515795PMCID PMC2735065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A European view managed care health plans: better or cheaper treatment strategies?

  2009cited by this paper
• Applied Survival Analysis: Regression Modeling of Time-to-Event Data

  2008cited by this paper
• Aggressive Surgery Improves Long-term Survival in Neuroendocrine Pancreatic Tumors: An Institutional Experience

  2007cited by this paper
• Rationale for the use of somatostatin analogs as antitumor agents.

  2006cited by this paper
• Endocrine tumours of the gastrointestinal tract. Biotherapy for metastatic endocrine tumours.

  2005cited by this paper
• Differences in Survival by Histologic Type of Pancreatic Cancer

  2005cited by this paper
• Biotherapy for metastatic endocrine tumours

  2005cited by this paper
• Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival?

  2005cited by this paper
• Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors.

  2005cited by this paper
• Non-islet origin of pancreatic islet cell tumors.

  2004cited by this paper
• Incidence and management of malignant digestive endocrine tumours in a well defined French population

  2004influential reference
• Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material

  2004cited by this paper
• Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

  2003cited by this paper
• Hepatic surgery for metastases from neuroendocrine tumors.

  2003cited by this paper
• Pancreaticoduodenectomy for Islet Cell Tumors of the Head of the Pancreas: Long-term Survival Analysis

  2002cited by this paper
• Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours.

  2001cited by this paper
• Applied Survival Analysis: Regression Modeling of Time to Event Data

  2000cited by this paper
• Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.

  1998cited by this paper
• Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients

  1998cited by this paper
• Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature.

  1997cited by this paper
• Islet Cell Carcinoma of the Pancreas

  1996cited by this paper
• Liver, gallbladder, extrahepatic bile ducts, and pancreas

  1995cited by this paper
• Is there a prognostic difference between functional and nonfunctional islet cell tumors?

  1994cited by this paper
• Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.

  1991cited by this paper
• Clinical pathology of endocrine tumors of the pancreas

  1991cited by this paper
• The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985.

  1989cited by this paper
• Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients.

  1989cited by this paper
• Pancreatic endocrine tumors.

  1988cited by this paper
• Islet cell carcinomas of the pancreas: a twenty-year experience.

  1988cited by this paper
• Neuroendocrine tumors: A European view

  1986cited by this paper
• Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.

  1985cited by this paper
• Islet cell carcinoma of the pancreas.

  1975cited by this paper
• Islet cell carcinoma of the pancreas.

  1975cited by this paper
• Epidemiology of pancreatic cancer in Connecticut.

  1968cited by this paper

• Pancreatic Metastases from Clear Cell Renal Cell Carcinoma: Diagnostic Insights from Endoscopic Ultrasound-Guided Fine-Needle Biopsy.

  2026cites this paper
• Systematic review of multimodal management strategies for Insulinoma-Induced hypoglycaemia: current evidence and future directions

  2026cites this paper
• Real-world treatment outcomes for pancreatic neuroendocrine tumours: a single tertiary referral institute experience

  2026cites this paper
• Pancreatic Neuroendocrine Tumors: From Benchside to Surgical Treatment

  2026cites this paper
• Differentiating cytology of pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors by EUS-FNA through hyperspectral imaging technology combined with artificial intelligence

  2026cites this paper
• Radiomics in Pancreatic Neuroendocrine Tumors (PNETs): Current Evidence, Reproducibility Gaps, and Research Directions

  2026cites this paper
• Imaging Features of Pancreatic Neuroendocrine Tumors Following Radiofrequency Ablation: Early Experience.

  2026cites this paper
• Ga-68-Edotreotide PET/CT SSTR Total Tumor Volume as a Predictor of Outcome in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

  2026cites this paper
• Clinical Relevance of ATRX/DAXX Gene Mutations and ALT in Functioning Pancreatic Neuroendocrine Tumors

  2025cites this paper
• Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors.

  2025cites this paper
• Imaging Update of Pancreatic Neuroendocrine Neoplasms.

  2025cites this paper
• Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma

  2025influential citation
• A nomogram for predicting the risk of liver metastasis in non-functional neuroendocrine neoplasms: A population-based study.

  2025cites this paper
• DNA methyltransferase 1 correlates with immune modulation in pancreatic neuroendocrine tumors

  2025cites this paper
• Prognosis of small pancreatic neuroendocrine neoplasms: Functionality matters.

  2025cites this paper
• Incidence and risk factors for insulinoma diagnosed in dogs under primary veterinary care in the UK

  2025cites this paper
• Patient-Derived Organoids from Pancreatic Neuroendocrine Tumors: A Systematic Review of PDO Take Rates, Molecular–Biological Characteristics, and Potential for Clinical Utility

  2025cites this paper
• Prognosis of NETs: Has There Been Improvement over the Last 30 Years?

  2025cites this paper
• Small needle biopsies of pancreatic neuroendocrine tumors: pitfalls, perils, and challenges

  2025cites this paper
• Dethroning of Neuroendocrine Tumor as an Orphan Disease: US Incidence, Prevalence, and Survival in the 21st Century

  2025cites this paper
• Gastroenteropancreatic Neuroendocrine Tumors: Does Tumor Location Affect Prognosis?

  2025cites this paper
• Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy

  2025cites this paper
• Endoscopic ultrasound imaging of pancreatic cysts

  2025cites this paper
• The Role of Primary Tumor Resection in Surgical Management of Asymptomatic Metastatic PNETs: A Retrospective Single-Center Study.

  2025cites this paper
• A Challenging Decision: Identifying and Managing Hepatic Hydrothorax in the Setting of a Pancreatic Neuroendocrine Tumor

  2025cites this paper
• Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report

  2025cites this paper
• Glucagon-like peptide-1 receptor PET/CT with 68Ga-exendin-4 for localizing insulinoma: a real-world, single-center study

  2025cites this paper
• Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in 177Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumors

  2025cites this paper
• Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups.

  2025cites this paper
• Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors

  2025cites this paper
• The relationship between remnant cholesterol and WHO grade of pancreatic neuroendocrine neoplasms

  2025cites this paper
• Evolving Surgical Approaches in the Management of Pancreatic Masses: From Open Resection to Minimally Invasive and Robotic Techniques

  2025cites this paper
• Well-differentiated grade 1 and 2 nonfunctioning pancreatic neuroendocrine tumor: Consideration of additional factors to aid treatment decision-making.

  2025cites this paper
• Pancreatic neuroendocrine neoplasms: current paradigms and diagnostic challenges.

  2025cites this paper
• Variable Imaging Appearances and Diagnostic Certainty Challenges in Confirming Pancreatic Neuroendocrine Tumours (NET): A Case Report

  2025cites this paper
• Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization

  2025cites this paper
• Management and outcomes of pediatric neuroendocrine tumors - A systematic review of published studies.

  2025cites this paper
• Decoding Pancreatic Neuroendocrine Tumors: Molecular Profiles, Biomarkers, and Pathways to Personalized Therapy

  2025cites this paper
• Comparative analysis of streptozocin-based regimen and capecitabine–temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index

  2025cites this paper
• Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors

  2025cites this paper
• Emerging innovations in theranostics for pancreatic neuroendocrine tumors

  2025influential citation
• A systematic Mendelian randomized study of the effects of the gut microbiome and immune cells on pancreatic neuroendocrine tumors

  2025cites this paper
• Innovative nanoparticle-based therapies for pancreatic neuroendocrine tumours (PNETs): advances, challenges, and future directions

  2025cites this paper
• The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors

  2025cites this paper
• Gastroenteropancreatic Neuroendocrine Tumors.

  2025cites this paper
• Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy

  2025cites this paper
• Surgical Management of Gastroenteropancreatic Neuroendocrine Tumors

  2025cites this paper
• Pancreatic Neuroendocrine Tumors—A Descriptive Study of the Presenting Features in a 20-Year Surgical Resection Cohort at a Tertiary Institution

  2025cites this paper
• Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications

  2025cites this paper
• New Treatment Options for Pancreatic Neuroendocrine Tumors: A Narrative Review

  2025cites this paper
• Acute Encephalopathy and Severe Hypercalcemia as the Initial Presentation of a Large Parathyroid Hormone-Related Protein (PTHrP)-Secreting Pancreatic Neuroendocrine Tumor: A Case Report

  2025cites this paper
• Outcomes Following Surgery for Pancreatic Neuro-Endocrine Tumours: A Single-Centre Experience

  2025cites this paper
• Intraoperative hepatic ultrasonography in patients with gastrointestinal and pancreatic neuroendocrine neoplasms without preoperative evidence of liver metastases

  2025cites this paper
• Enhancing the stability of 68Ga-labeled RNA aptamers for pancreatic β-cell and insulinoma imaging through nucleoside modifications

  2025cites this paper
• The Silent Presentation of a Non-functioning Pancreatic Neuroendocrine Tumor: A Case Report

  2025influential citation
• Prevalence, characteristics, and management of pancreatic tumors among children with tuberous sclerosis complex.

  2025cites this paper
• Aktuelle Standards in der Diagnostik und chirurgischen Therapie pankreatischer neuroendokriner Tumoren

  2025cites this paper
• Incidence, clinical features and survival among patients with functional pancreatic neuroendrocrine tumors

  2024cites this paper
• Usefulness of intratumoral perfusion analysis for assessing biological features of non-functional pancreatic neuroendocrine neoplasm

  2024cites this paper
• Homologous recombination deficiency in pancreatic neuroendocrine tumors.

  2024cites this paper
• Neuroendocrine tumors of the stomach and pancreas. Possibilities of application of radiomics. Problems and solutions.

  2024cites this paper
• Genetic syndromes associated with pancreatic neuroendocrine neoplasms and imaging diagnostic strategies

  2024cites this paper
• EUS–radiofrequency ablation for pancreatic neuroendocrine tumors: Is there a promising future?

  2024cites this paper
• Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms

  2024cites this paper
• Artificial Intelligence in Pancreatic Image Analysis: A Review

  2024cites this paper
• Oncogenic pathway signatures predict the risk of progression and recurrence in well‐differentiated pancreatic neuroendocrine tumors

  2024cites this paper
• Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis

  2024cites this paper
• Neuroendocrine Neoplasms.

  2024cites this paper
• MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer

  2024cites this paper
• Contemporary Approaches to the Surgical Management of Pancreatic Neuroendocrine Tumors

  2024influential citation
• Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review

  2024cites this paper
• Nucleocytoplasmic β‐catenin expression contributes to neuroendocrine differentiation in muscle invasive bladder cancer

  2024cites this paper
• Advances in Management of Nonfunctional Pancreas Neuroendocrine Tumors.

  2024cites this paper
• A Rare Presentation of Lymph Node Metastasis of VIPoma After Three Years of Resection: A Case Report

  2024cites this paper
• Pancreatic neuroendocrine tumour resection in circumportal pancreas: a rare anatomical anomaly with important surgical implications

  2024cites this paper
• Cinematic Rendering of Pancreatic Neuroendocrine Tumours: Opportunities for Clinical Implementation: Part 1: Tumour Detection and Characterization

  2024cites this paper
• X Ray-Induced Insulinoma Cell Line Rin-5F Has a Novel Mutation Site, C.A1459G (P.T487A), in Death Domain Associated Protein (DAXX) Gene

  2024cites this paper
• Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns

  2024cites this paper
• Clinical and CT Quantitative Features for Predicting Liver Metastases in Patients with Pancreatic Neuroendocrine Tumors: A Study with Prospective/External Validation.

  2024cites this paper
• Diagnostics and Imaging for Pancreatic Neuroendocrine Tumors.

  2024cites this paper
• Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors

  2024cites this paper
• High-grade neuroendocrine neoplasms of the pancreas:A case report and literature review.

  2024cites this paper
• Pancreatic Neuroendocrine Tumor Associated with Carcinoid Heart Disease: A Case Report and Review of Literature

  2024cites this paper
• Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?

  2024cites this paper
• Imaging differentiation of solid pseudopapillary neoplasms and neuroendocrine neoplasms of the pancreas

  2024cites this paper
• Disease-free survival after pancreatectomy for pancreatic neuroendocrine tumours: a 17-year single-center experience of 223 patients.

  2024cites this paper
• Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis

  2024cites this paper
• Endoscopic loco-regional treatment in controlling pancreatic neuroendocrine tumors (PNETs) behavior: a case series and literature review

  2024cites this paper
• Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy.

  2024cites this paper
• Incidence and survival of patients with malignant pancreatic neuroendocrine neoplasms in Germany, 2009-2021.

  2024cites this paper
• Robotic Versus Laparoscopic Versus Open Surgery for Non-Metastatic Pancreatic Neuroendocrine Tumors (pNETs): A Systematic Review and Network Meta-Analysis

  2024cites this paper
• Detection of Alternative Lengthening of Telomeres via Chromogenic in situ Hybridization (ALT-CISH) for the Prognostication of PanNETs and Other Neoplasms.

  2024cites this paper
• Developing a peripheral blood RNA‐seq based NETseq ensemble classifier: A potential novel tool for non‐invasive detection and treatment response assessment in neuroendocrine tumor patients receiving 177Lu‐DOTATATE PRRT

  2024cites this paper
• A Rare and Aggressive Case of Malignant Insulinoma

  2024cites this paper
• Современные взгляды на лечение инсулиномы

  2024cites this paper
• Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice

  2024cites this paper
• C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors

  2023cites this paper
• Tumor vascularity on contrast-enhanced computed tomography as a predictive marker of metastatic potential for small nonfunctioning pancreatic neuroendocrine tumors.

  2023cites this paper
• Surgical Management of Pancreatic Neuroendocrine Tumors

  2023cites this paper
• Diagnostik von neuroendokrinen Neoplasien am Beispiel der GEP-NEN

  2023cites this paper